Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,735
archived clinical trials in
Psoriasis

Study to Assess the Immunogenicity and Safety of Etanercept Produced in Plaque Psoriasis
A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis
Status: Enrolling
Updated:  2/8/2016
Clinical Research Facility
mi
from
Nashville, TN
Study to Assess the Immunogenicity and Safety of Etanercept Produced in Plaque Psoriasis
A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis
Status: Enrolling
Updated: 2/8/2016
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of Etanercept Produced in Plaque Psoriasis
A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis
Status: Enrolling
Updated:  2/8/2016
Clinical Research Facility
mi
from
Bellaire, TX
Study to Assess the Immunogenicity and Safety of Etanercept Produced in Plaque Psoriasis
A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis
Status: Enrolling
Updated: 2/8/2016
Clinical Research Facility
mi
from
Bellaire, TX
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of Etanercept Produced in Plaque Psoriasis
A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis
Status: Enrolling
Updated:  2/8/2016
Clinical Research Facility
mi
from
Dallas, TX
Study to Assess the Immunogenicity and Safety of Etanercept Produced in Plaque Psoriasis
A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis
Status: Enrolling
Updated: 2/8/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of Etanercept Produced in Plaque Psoriasis
A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis
Status: Enrolling
Updated:  2/8/2016
Clinical Research Facility
mi
from
Dallas, TX
Study to Assess the Immunogenicity and Safety of Etanercept Produced in Plaque Psoriasis
A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis
Status: Enrolling
Updated: 2/8/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of Etanercept Produced in Plaque Psoriasis
A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis
Status: Enrolling
Updated:  2/8/2016
Clinical Research Facility
mi
from
San Antonio, TX
Study to Assess the Immunogenicity and Safety of Etanercept Produced in Plaque Psoriasis
A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis
Status: Enrolling
Updated: 2/8/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of Etanercept Produced in Plaque Psoriasis
A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis
Status: Enrolling
Updated:  2/8/2016
Clinical Research Facility
mi
from
San Antonio, TX
Study to Assess the Immunogenicity and Safety of Etanercept Produced in Plaque Psoriasis
A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis
Status: Enrolling
Updated: 2/8/2016
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of Etanercept Produced in Plaque Psoriasis
A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis
Status: Enrolling
Updated:  2/8/2016
Clinical Research Facility
mi
from
Norfolk, VA
Study to Assess the Immunogenicity and Safety of Etanercept Produced in Plaque Psoriasis
A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis
Status: Enrolling
Updated: 2/8/2016
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Study to Assess the Immunogenicity and Safety of Etanercept Produced in Plaque Psoriasis
A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis
Status: Enrolling
Updated:  2/8/2016
Research Site
mi
from
Surrey,
Study to Assess the Immunogenicity and Safety of Etanercept Produced in Plaque Psoriasis
A Single-arm Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Subjects With Plaque Psoriasis
Status: Enrolling
Updated: 2/8/2016
Research Site
mi
from
Surrey,
Click here to add this to my saved trials
Photocil (Topical) for the Treatment of Psoriasis Vulgaris
Pilot Study of Novel Topical Drug (Photocil) for the Treatment of Psoriasis Vulgaris
Status: Enrolling
Updated:  2/12/2016
Physicians Institute
mi
from
Tucson, AZ
Photocil (Topical) for the Treatment of Psoriasis Vulgaris
Pilot Study of Novel Topical Drug (Photocil) for the Treatment of Psoriasis Vulgaris
Status: Enrolling
Updated: 2/12/2016
Physicians Institute
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants
A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants
Status: Enrolling
Updated:  2/17/2016
Reliance Clinical Testing Service
mi
from
Irving, TX
A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants
A Single-Center, Exploratory Study to Analyze the Dynamics of Skin Microflora Following Exposure to Surfactants
Status: Enrolling
Updated: 2/17/2016
Reliance Clinical Testing Service
mi
from
Irving, TX
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
Yale University
mi
from
New Haven, CT
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
The Feinstein Institute for Medical Research
mi
from
Manhasset, NY
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
The Feinstein Institute for Medical Research
mi
from
Manhasset, NY
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
University of Rochester
mi
from
Rochester, NY
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
University of Rochester
mi
from
Rochester, NY
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
Oklahoma Medical Research Foundation
mi
from
Oklahoma City, OK
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
Oklahoma Medical Research Foundation
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
Baylor Institute of Immunology Research - Clinical Rheumatology
mi
from
Dallas, TX
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
Baylor Institute of Immunology Research - Clinical Rheumatology
mi
from
Dallas, TX
Click here to add this to my saved trials
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated:  2/21/2016
Emory University
mi
from
Atlanta, GA
T and B Cell Responses in Autoimmune Diseases
T and B Cell Responses Across Autoimmune Diseases
Status: Enrolling
Updated: 2/21/2016
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Randomized, Multicentric, Controlled Study on the Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Status: Enrolling
Updated:  2/23/2016
Hamzavi Dermatology/Dermatology Specialists of Canton
mi
from
Canton, MI
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Randomized, Multicentric, Controlled Study on the Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Status: Enrolling
Updated: 2/23/2016
Hamzavi Dermatology/Dermatology Specialists of Canton
mi
from
Canton, MI
Click here to add this to my saved trials
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Randomized, Multicentric, Controlled Study on the Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Status: Enrolling
Updated:  2/23/2016
Hamzavi Dermatology
mi
from
Fort Gratiot, MI
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Randomized, Multicentric, Controlled Study on the Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Status: Enrolling
Updated: 2/23/2016
Hamzavi Dermatology
mi
from
Fort Gratiot, MI
Click here to add this to my saved trials
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Randomized, Multicentric, Controlled Study on the Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Status: Enrolling
Updated:  2/23/2016
Lynderm Research
mi
from
Markham,
Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Randomized, Multicentric, Controlled Study on the Daily Use of Lipikar Balm AP From Birth in Infants at High Risk of Developing Atopic Dermatitis
Status: Enrolling
Updated: 2/23/2016
Lynderm Research
mi
from
Markham,
Click here to add this to my saved trials
Photocil (Topical) for the Treatment of Atopic Dermatitis
Pilot Study of Novel Topical Drug (Photocil) for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated:  2/25/2016
Physicians Institute
mi
from
Tucson, AZ
Photocil (Topical) for the Treatment of Atopic Dermatitis
Pilot Study of Novel Topical Drug (Photocil) for the Treatment of Atopic Dermatitis
Status: Enrolling
Updated: 2/25/2016
Physicians Institute
mi
from
Tucson, AZ
Click here to add this to my saved trials
Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database
A Large US Health Insurance Claims Database Will be Used to Estimate the Incidence of Serious Outcomes in Patients With Psoriasis Treated With Ustekinumab and Other Types of Biological and Systemic Non-biological Treatments
Status: Enrolling
Updated:  2/26/2016
Ingenix - i3 Drug Safety
mi
from
Waltham, MA
Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database
A Large US Health Insurance Claims Database Will be Used to Estimate the Incidence of Serious Outcomes in Patients With Psoriasis Treated With Ustekinumab and Other Types of Biological and Systemic Non-biological Treatments
Status: Enrolling
Updated: 2/26/2016
Ingenix - i3 Drug Safety
mi
from
Waltham, MA
Click here to add this to my saved trials
Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population
An Open -Label Study to Evaluate the Effect of Pandel Cream 0.1% on the Hypothalamic Pituitary Adrenal Axis in the Pediatric and Adult Population
Status: Enrolling
Updated:  2/26/2016
Christopher Huerter, MD
mi
from
Omaha, NE
Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population
An Open -Label Study to Evaluate the Effect of Pandel Cream 0.1% on the Hypothalamic Pituitary Adrenal Axis in the Pediatric and Adult Population
Status: Enrolling
Updated: 2/26/2016
Christopher Huerter, MD
mi
from
Omaha, NE
Click here to add this to my saved trials
Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population
An Open -Label Study to Evaluate the Effect of Pandel Cream 0.1% on the Hypothalamic Pituitary Adrenal Axis in the Pediatric and Adult Population
Status: Enrolling
Updated:  2/26/2016
Oswald Mikell, MD
mi
from
Hilton Head Island, SC
Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population
An Open -Label Study to Evaluate the Effect of Pandel Cream 0.1% on the Hypothalamic Pituitary Adrenal Axis in the Pediatric and Adult Population
Status: Enrolling
Updated: 2/26/2016
Oswald Mikell, MD
mi
from
Hilton Head Island, SC
Click here to add this to my saved trials
Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population
An Open -Label Study to Evaluate the Effect of Pandel Cream 0.1% on the Hypothalamic Pituitary Adrenal Axis in the Pediatric and Adult Population
Status: Enrolling
Updated:  2/26/2016
Michael Gold, MD
mi
from
Nashville, TN
Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population
An Open -Label Study to Evaluate the Effect of Pandel Cream 0.1% on the Hypothalamic Pituitary Adrenal Axis in the Pediatric and Adult Population
Status: Enrolling
Updated: 2/26/2016
Michael Gold, MD
mi
from
Nashville, TN
Click here to add this to my saved trials
A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06700841, With Bioavailability/Food Effect Investigation
A Phase 1, Within Cohort, Randomized, Double Blind, Third-party Open, Placebo-controlled, Single- And Multiple Dose Escalation, Parallel Group Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-06700841 In Healthy Subjects And Subjects With Plaque Psoriasis And Bioavailability Of A Tablet Formulation Relative To Suspension Formulation And The Effect Of Food On A Tablet Formulation Of Pf-06700841
Status: Enrolling
Updated:  3/2/2016
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
A Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06700841, With Bioavailability/Food Effect Investigation
A Phase 1, Within Cohort, Randomized, Double Blind, Third-party Open, Placebo-controlled, Single- And Multiple Dose Escalation, Parallel Group Study To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Pf-06700841 In Healthy Subjects And Subjects With Plaque Psoriasis And Bioavailability Of A Tablet Formulation Relative To Suspension Formulation And The Effect Of Food On A Tablet Formulation Of Pf-06700841
Status: Enrolling
Updated: 3/2/2016
Anaheim Clinical Trials, LLC
mi
from
Anaheim, CA
Click here to add this to my saved trials
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Status: Enrolling
Updated:  3/10/2016
Center for Dermatology Clinical Research
mi
from
Fremont, CA
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Status: Enrolling
Updated: 3/10/2016
Center for Dermatology Clinical Research
mi
from
Fremont, CA
Click here to add this to my saved trials
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Status: Enrolling
Updated:  3/10/2016
UCSD Dermatology
mi
from
San Diego, CA
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Status: Enrolling
Updated: 3/10/2016
UCSD Dermatology
mi
from
San Diego, CA
Click here to add this to my saved trials
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Status: Enrolling
Updated:  3/10/2016
Altman Dermatology Associates
mi
from
Arlington Heights, IL
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Status: Enrolling
Updated: 3/10/2016
Altman Dermatology Associates
mi
from
Arlington Heights, IL
Click here to add this to my saved trials
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Status: Enrolling
Updated:  3/10/2016
Minnesota Clinical Study Center
mi
from
Fridley, MN
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Status: Enrolling
Updated: 3/10/2016
Minnesota Clinical Study Center
mi
from
Fridley, MN
Click here to add this to my saved trials
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Status: Enrolling
Updated:  3/10/2016
Wilmington Dermatology Center
mi
from
Wilmington, NC
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Status: Enrolling
Updated: 3/10/2016
Wilmington Dermatology Center
mi
from
Wilmington, NC
Click here to add this to my saved trials
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Status: Enrolling
Updated:  3/10/2016
Oregon Medical Research Center, PC
mi
from
Portland, OR
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Status: Enrolling
Updated: 3/10/2016
Oregon Medical Research Center, PC
mi
from
Portland, OR
Click here to add this to my saved trials
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Status: Enrolling
Updated:  3/10/2016
Clinical Partners, LLC
mi
from
Johnston, RI
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Status: Enrolling
Updated: 3/10/2016
Clinical Partners, LLC
mi
from
Johnston, RI
Click here to add this to my saved trials
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Status: Enrolling
Updated:  3/10/2016
Research Across America
mi
from
Dallas, TX
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Status: Enrolling
Updated: 3/10/2016
Research Across America
mi
from
Dallas, TX
Click here to add this to my saved trials
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Status: Enrolling
Updated:  3/10/2016
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Status: Enrolling
Updated: 3/10/2016
Virginia Clinical Research, Inc.
mi
from
Norfolk, VA
Click here to add this to my saved trials
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Status: Enrolling
Updated:  3/10/2016
Henry Ford Health System
mi
from
Detroit, MI
A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -304)
Status: Enrolling
Updated: 3/10/2016
Henry Ford Health System
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis
A Double-blind, Randomized, Multicenter, Vehicle-Controlled Parallel Group Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis Receiving Two Weeks of Treatment
Status: Enrolling
Updated:  3/10/2016
Therapeutics Clinical Research
mi
from
San Diego, CA
A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis
A Double-blind, Randomized, Multicenter, Vehicle-Controlled Parallel Group Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis Receiving Two Weeks of Treatment
Status: Enrolling
Updated: 3/10/2016
Therapeutics Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis
A Double-blind, Randomized, Multicenter, Vehicle-Controlled Parallel Group Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis Receiving Two Weeks of Treatment
Status: Enrolling
Updated:  3/10/2016
Minnesota Clinical Study Center
mi
from
Fridley, MN
A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis
A Double-blind, Randomized, Multicenter, Vehicle-Controlled Parallel Group Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis Receiving Two Weeks of Treatment
Status: Enrolling
Updated: 3/10/2016
Minnesota Clinical Study Center
mi
from
Fridley, MN
Click here to add this to my saved trials
A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis
A Double-blind, Randomized, Multicenter, Vehicle-Controlled Parallel Group Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis Receiving Two Weeks of Treatment
Status: Enrolling
Updated:  3/10/2016
DermResearch, Inc.
mi
from
Austin, TX
A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis
A Double-blind, Randomized, Multicenter, Vehicle-Controlled Parallel Group Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis Receiving Two Weeks of Treatment
Status: Enrolling
Updated: 3/10/2016
DermResearch, Inc.
mi
from
Austin, TX
Click here to add this to my saved trials
Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
A Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
Status: Enrolling
Updated:  3/11/2016
Arrowhead Health Centers
mi
from
Glendale, AZ
Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
A Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
Status: Enrolling
Updated: 3/11/2016
Arrowhead Health Centers
mi
from
Glendale, AZ
Click here to add this to my saved trials
Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
A Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
Status: Enrolling
Updated:  3/11/2016
Southern California Dermatology, Inc.
mi
from
Santa Ana, CA
Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
A Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
Status: Enrolling
Updated: 3/11/2016
Southern California Dermatology, Inc.
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
A Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
Status: Enrolling
Updated:  3/11/2016
Shondra L Smith, MD
mi
from
Lake Charles, LA
Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
A Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
Status: Enrolling
Updated: 3/11/2016
Shondra L Smith, MD
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
A Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
Status: Enrolling
Updated:  3/11/2016
Massachusetts General Hospital
mi
from
Boston, MA
Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
A Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
Status: Enrolling
Updated: 3/11/2016
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
A Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
Status: Enrolling
Updated:  3/11/2016
Clinical Studies Group, LLC
mi
from
Henderson, NV
Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
A Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
Status: Enrolling
Updated: 3/11/2016
Clinical Studies Group, LLC
mi
from
Henderson, NV
Click here to add this to my saved trials
Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
A Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
Status: Enrolling
Updated:  3/11/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
A Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
Status: Enrolling
Updated: 3/11/2016
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
A Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
Status: Enrolling
Updated:  3/11/2016
High Point Clinical Trials Center
mi
from
High Point, NC
Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
A Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
Status: Enrolling
Updated: 3/11/2016
High Point Clinical Trials Center
mi
from
High Point, NC
Click here to add this to my saved trials
Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
A Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
Status: Enrolling
Updated:  3/11/2016
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
A Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
Status: Enrolling
Updated: 3/11/2016
Altoona Center for Clinical Research
mi
from
Duncansville, PA
Click here to add this to my saved trials
Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
A Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
Status: Enrolling
Updated:  3/11/2016
Metroplex Clinical Research Center (MCRC)
mi
from
Dallas, TX
Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
A Phase 2, Open-Label, Dose-Finding Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy
Status: Enrolling
Updated: 3/11/2016
Metroplex Clinical Research Center (MCRC)
mi
from
Dallas, TX
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Lebanon, NH
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Lebanon, NH
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Peoria, AZ
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Peoria, AZ
Click here to add this to my saved trials
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
AMG 827 in Subjects With Psoriatic Arthritis
A Randomized, Double-blinded, Placebo-controlled, Multiple-dose Study With an Open Label Extension to Evaluate the Safety and Efficacy of AMG 827 in Subjects With Psoriatic Arthritis.
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
mi
from
Scottsdale, AZ
Click here to add this to my saved trials